Finance

Lists
ASTRAZEN:NSE
Astrazeneca Pharma India Ltd
₹8,110.00
-0.92%
(-75.00) 1D
Jul 30, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ASTRAZEN...
Open
₹8,180.00
High
₹8,199.50
Low
₹8,065.00
Mkt. cap
202.16B
Avg. vol.
6.72K
Volume
1.63K
Dividend
0.44%
Quarterly dividend
₹9.00
Ex-dividend date
Jul 31, 2026
P/E ratio
108.12
52-wk high
₹9,849.50
52-wk low
₹7,551.50
EPS
₹75.01
Shares outstanding
25.00M
No. of employees
760
Open
₹8,180.00
High
₹8,199.50
Low
₹8,065.00
Mkt. cap
202.16B
Avg. vol.
6.72K
Volume
1.63K
Dividend
0.44%
Quarterly dividend
₹9.00
Ex-dividend date
Jul 31, 2026
P/E ratio
108.12
52-wk high
₹9,849.50
52-wk low
₹7,551.50
EPS
₹75.01
Shares outstanding
25.00M
No. of employees
760
News stories
From sources across the web
About Astrazeneca Pharma India Ltd
CEO-
Employees760
Founded1979
Headquarters-
SectorPharmaceutical industry
Last report
May 26, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
5.79B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.26B
5.59B
6.12B
5.79B
Cost of goods sold
2.95B
3.24B
3.66B
3.98B
Cost of revenue
2.95B
3.24B
3.66B
3.98B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
864.70M
884.60M
1.30B
-392.20M
Operating expense
1.66B
1.62B
2.04B
1.25B
Total operating expenses
4.62B
4.86B
5.71B
5.23B
Operating income
645.40M
726.10M
409.90M
556.00M
Other non operating income
112.40M
61.70M
51.30M
-175.20M
EBT including unusual items
747.00M
728.20M
465.40M
581.40M
EBT excluding unusual items
750.60M
781.10M
450.60M
593.50M
Income tax expense
188.70M
186.00M
139.50M
132.60M
Effective tax rate
25.26%
25.54%
29.97%
22.81%
Other operating expenses
611.10M
655.10M
694.70M
1.49B
Net income
558.30M
542.20M
325.90M
448.80M
Net profit margin
10.61%
9.70%
5.33%
7.76%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
232.00M
Interest expense
-7.20M
-6.70M
-10.60M
-20.40M
Net interest expenses
-7.20M
-6.70M
-10.60M
211.60M
Depreciation and amortization charges
165.70M
25.70M
38.40M
56.00M
EBITDA
729.48M
821.80M
493.98M
598.30M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps